{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:59:04Z","timestamp":1793951944863,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64669-4","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:21:02Z","timestamp":1762176062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Rational design of potent small-molecule SMARCA2\/A4 degraders acting via the recruitment of FBXO22"],"prefix":"10.1038","volume":"16","author":[{"given":"Elisia","family":"Villemure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Januario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshuo","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna G.","family":"Budayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5400-0696","authenticated-orcid":false,"given":"Benjamin T.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Lictao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke Sherry","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline L.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Hoag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1086-6048","authenticated-orcid":false,"given":"Nicholas F.","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy K.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Ishisoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett M.","family":"Babin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Frommlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-6106","authenticated-orcid":false,"given":"Joachim","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9478-6283","authenticated-orcid":false,"given":"Robert L.","family":"Yauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"64669_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.chembiol.2023.06.020","volume":"30","author":"M Teng","year":"2023","unstructured":"Teng, M. & Gray, N. S. The rise of degrader drugs. Cell Chem. Biol. 30, 864\u2013878 (2023).","journal-title":"Cell Chem. Biol."},{"key":"64669_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41573-023-00652-2","volume":"22","author":"MNO Laramy","year":"2023","unstructured":"Laramy, M. N. O., Luthra, S., Brown, M. F. & Bartlett, D. W. Delivering on the promise of protein degraders. Nat. Rev. Drug Discov. 22, 410\u2013427 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"64669_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","volume":"25","author":"JM Tsai","year":"2024","unstructured":"Tsai, J. M., Nowak, R. P., Ebert, B. L. & Fischer, E. S. Targeted protein degradation: from mechanisms to clinic. Nat. Rev. Mol. Cell Biol. 25, 740\u2013757 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"64669_CR4","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.1021\/acs.jmedchem.3c00740","volume":"66","author":"KR Hornberger","year":"2023","unstructured":"Hornberger, K. R. & Araujo, E. M. V. Physicochemical property determinants of oral absorption for PROTAC protein degraders. J. Med. Chem. 66, 8281\u20138287 (2023).","journal-title":"J. Med. Chem."},{"key":"64669_CR5","doi-asserted-by":"publisher","first-page":"20242","DOI":"10.1021\/acs.jmedchem.4c01642","volume":"67","author":"ZS Valencia","year":"2024","unstructured":"Valencia, Z. S. et al. Closing the design\u2013make\u2013test\u2013analyze loop: interplay between experiments and predictions drives PROTACs bioavailability. J. Med. Chem. 67, 20242\u201320257 (2024).","journal-title":"J. Med. Chem."},{"key":"64669_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","volume":"184","author":"SL Schreiber","year":"2021","unstructured":"Schreiber, S. L. The rise of molecular glues. Cell 184, 3\u20139 (2021).","journal-title":"Cell"},{"key":"64669_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1021\/acs.biochem.2c00245","volume":"62","author":"JM Sasso","year":"2023","unstructured":"Sasso, J. M. et al. Molecular glues: the adhesive connecting targeted protein degradation to the clinic. Biochemistry 62, 601\u2013623 (2023).","journal-title":"Biochemistry"},{"key":"64669_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/17460441.2024.2306845","volume":"19","author":"T Lemaitre","year":"2024","unstructured":"Lemaitre, T. et al. Molecular glue degraders: exciting opportunities for novel drug discovery. Expert Opin. Drug Discov. 19, 433\u2013449 (2024).","journal-title":"Expert Opin. Drug Discov."},{"key":"64669_CR9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1021\/acscentsci.4c00286","volume":"10","author":"M Lim","year":"2024","unstructured":"Lim, M. et al. DCAF16-based covalent handle for the rational design of monovalent degraders. ACS Cent. Sci. 10, 1318\u20131331 (2024).","journal-title":"ACS Cent. Sci."},{"key":"64669_CR10","doi-asserted-by":"crossref","unstructured":"Zhuang, Z. et al. Discovery of electrophilic degraders that exploit SNAr chemistry. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2024.09.25.615094v1 (2024).","DOI":"10.1101\/2024.09.25.615094"},{"key":"64669_CR11","doi-asserted-by":"crossref","unstructured":"Shaum, J. B. et al. High-throughput diversification of protein-ligand surfaces to discover chemical inducers of proximity. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2024.09.30.615685v1 (2024).","DOI":"10.1101\/2024.09.30.615685"},{"key":"64669_CR12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/acscentsci.2c01317","volume":"9","author":"ES Toriki","year":"2023","unstructured":"Toriki, E. S. et al. Rational chemical design of molecular glue degraders. ACS Cent. Sci. 9, 915\u2013926 (2023).","journal-title":"ACS Cent. Sci."},{"key":"64669_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1021\/acschembio.3c00312","volume":"19","author":"PE Cockram","year":"2024","unstructured":"Cockram, P. E. et al. Allosteric inhibitors of the SARS-COV\u20112 papain-like protease domain induce proteasomal degradation of its parent protein NSP3. ACS Chem. Biol. 19, 22\u201336 (2024).","journal-title":"ACS Chem. Biol."},{"key":"64669_CR14","doi-asserted-by":"crossref","unstructured":"Zhuang, Z. et al. Charged molecular glue discovery enabled by targeted degron display. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2024.09.24.614843v1 (2024).","DOI":"10.1101\/2024.09.24.614843"},{"key":"64669_CR15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41589-024-01668-4","volume":"20","author":"Y-D Li","year":"2024","unstructured":"Li, Y.-D. et al. Template-assisted covalent modification underlies activity of covalent molecular glues. Nat. Chem. Biol. 20, 1640\u20131649 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"64669_CR16","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1158\/1535-7163.MCT-24-0219","volume":"23","author":"GS Parker","year":"2024","unstructured":"Parker, G. S. et al. Discovery of monovalent direct degraders of BRD4 that act via the recruitment of DCAF11. Mol. Cancer Ther. 23, 1446\u20131458 (2024).","journal-title":"Mol. Cancer Ther."},{"key":"64669_CR17","doi-asserted-by":"publisher","first-page":"11841","DOI":"10.1021\/acs.jmedchem.1c00847","volume":"64","author":"J Liang","year":"2021","unstructured":"Liang, J. et al. GDC-9545 (Giredestrant): a potent and orally bioavailable selective estrogen receptor antagonist and degrader with an exceptional preclinical profile for ER+breast Cancer. J. Med. Chem. 64, 11841\u201311856 (2021).","journal-title":"J. Med. Chem."},{"key":"64669_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1158\/2159-8290.CD-21-0072","volume":"12","author":"KW Song","year":"2021","unstructured":"Song, K. W. et al. RTK-dependent inducible degradation of mutant PI3K\u03b1 drives GDC-0077 (Inavolisib) efficacy. Cancer Discov. 12, 204\u2013219 (2021).","journal-title":"Cancer Discov."},{"key":"64669_CR19","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1016\/j.celrep.2017.08.081","volume":"20","author":"N Kerres","year":"2017","unstructured":"Kerres, N. et al. Chemically induced degradation of the oncogenic transcription factor BCL6. Cell Rep. 20, 2860\u20132875 (2017).","journal-title":"Cell Rep."},{"key":"64669_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-020-2374-x","volume":"585","author":"M S\u0142abicki","year":"2020","unstructured":"S\u0142abicki, M. et al. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K. Nature 585, 293\u2013297 (2020).","journal-title":"Nature"},{"key":"64669_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1021\/acschembio.2c00747","volume":"18","author":"AG Shergalis","year":"2023","unstructured":"Shergalis, A. G. et al. CRISPR screen reveals BRD2\/4 molecular glue-like degrader via recruitment of DCAF16. ACS Chem. Biol. 18, 331\u2013339 (2023).","journal-title":"ACS Chem. Biol."},{"key":"64669_CR22","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1158\/0008-5472.CAN-14-3798","volume":"75","author":"B Vangamudi","year":"2015","unstructured":"Vangamudi, B. et al. The SMARCA2\/4 ATPase domain surpasses the bromodomain as a drug target in SWI\/SNF-mutant cancers: insights from cDNA rescue and PFI-3 inhibitor studies. Cancer Res. 75, 3865\u20133878 (2015).","journal-title":"Cancer Res."},{"key":"64669_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1021\/acs.jmedchem.3c01781","volume":"67","author":"M Berlin","year":"2024","unstructured":"Berlin, M. et al. PROTACs targeting BRM (SMARCA2) afford selective in vivo degradation over BRG1 (SMARCA4) and are active in BRG1 mutant xenograft tumor models. J. Med. Chem. 67, 1262\u20131313 (2024).","journal-title":"J. Med. Chem."},{"key":"64669_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41573-024-00978-5","volume":"23","author":"HA Malone","year":"2024","unstructured":"Malone, H. A. & Roberts, C. W. M. Chromatin remodellers as therapeutic targets. Nat. Rev. Drug Discov. 23, 661\u2013681 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"64669_CR25","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1073\/pnas.1316793111","volume":"111","author":"GR Hoffman","year":"2014","unstructured":"Hoffman, G. R. et al. Functional epigenetics approach identifies BRM\/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers. Proc. Natl. Acad. Sci. USA 111, 3128\u20133133 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64669_CR26","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1158\/0008-5472.CAN-12-4593","volume":"73","author":"T Oike","year":"2013","unstructured":"Oike, T. et al. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. Cancer Res. 73, 5508\u20135518 (2013).","journal-title":"Cancer Res."},{"key":"64669_CR27","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1038\/s41467-022-34562-5","volume":"13","author":"J Cantley","year":"2022","unstructured":"Cantley, J. et al. Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers. Nat. Commun. 13, 6814 (2022).","journal-title":"Nat. Commun."},{"key":"64669_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","volume":"601","author":"L Xiao","year":"2022","unstructured":"Xiao, L. et al. Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer. Nature 601, 434\u2013439 (2022).","journal-title":"Nature"},{"key":"64669_CR29","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41589-019-0294-6","volume":"15","author":"W Farnaby","year":"2019","unstructured":"Farnaby, W. et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat. Chem. Biol. 15, 672\u2013680 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"64669_CR30","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1182\/blood.2023022832","volume":"143","author":"W Fiskus","year":"2024","unstructured":"Fiskus, W. et al. BRG1\/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood 143, 2059\u20132072 (2024).","journal-title":"Blood"},{"key":"64669_CR31","doi-asserted-by":"publisher","first-page":"10155","DOI":"10.1021\/acs.jmedchem.8b01318","volume":"61","author":"JPN Papillon","year":"2018","unstructured":"Papillon, J. P. N. et al. Discovery of orally active inhibitors of brahma homolog (BRM)\/SMARCA2 ATPase activity for the treatment of brahma related gene 1 (BRG1)\/SMARCA4-mutant cancers. J. Med. Chem. 61, 10155\u201310172 (2018).","journal-title":"J. Med. Chem."},{"key":"64669_CR32","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1021\/acs.jmedchem.4c02535","volume":"68","author":"RG Vaswani","year":"2025","unstructured":"Vaswani, R. G. et al. Discovery of FHD-286, a first-in-class, orally bioavailable, allosteric dual inhibitor of the brahma homologue (BRM) and brahma-related gene 1 (BRG1) ATPase activity for the treatment of switch\/sucrose non-fermentable (SWI\/SNF) dependent cancers. J. Med. Chem. 68, 1772\u20131792 (2025).","journal-title":"J. Med. Chem."},{"key":"64669_CR33","doi-asserted-by":"publisher","first-page":"11177","DOI":"10.1021\/acs.jmedchem.2c00662","volume":"65","author":"AM Taylor","year":"2022","unstructured":"Taylor, A. M. et al. GNE-064: a potent, selective, and orally bioavailable chemical probe for the bromodomains of SMARCA2 and SMARCA4 and the fifth bromodomain of PBRM1. J. Med. Chem. 65, 11177\u201311186 (2022).","journal-title":"J. Med. Chem."},{"key":"64669_CR34","unstructured":"Albrecht, B. K. et al. Therapeutic Pyridazine Compounds and Uses Thereof. International publication No. WO2016138114A1, filed February 24, 2016, issued September 1, 2016."},{"key":"64669_CR35","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1093\/bioinformatics\/btm384","volume":"23","author":"K Borziak","year":"2007","unstructured":"Borziak, K. & Zhulin, I. B. FIST: a sensory domain for diverse signal transduction pathways in prokaryotes and ubiquitin signaling in eukaryotes. Bioinformatics 23, 2518\u20132521 (2007).","journal-title":"Bioinformatics"},{"key":"64669_CR36","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1016\/j.cell.2024.10.012","volume":"187","author":"S Cao","year":"2024","unstructured":"Cao, S. et al. Recognition of BACH1 quaternary structure degrons by two F-box proteins under oxidative stress. Cell 187, 7568\u20137584 (2024).","journal-title":"Cell"},{"key":"64669_CR37","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1016\/j.cell.2024.11.006","volume":"187","author":"B Goretzki","year":"2024","unstructured":"Goretzki, B. et al. Dual BACH1 regulation by complementary SCF-type E3 ligases. Cell 187, 7585\u20137602 (2024).","journal-title":"Cell"},{"key":"64669_CR38","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41589-024-01660-y","volume":"20","author":"DY Nie","year":"2024","unstructured":"Nie, D. Y. et al. Recruitment of FBXO22 for targeted degradation of NSD2. Nat. Chem. Biol. 20, 1597\u20131607 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"64669_CR39","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1038\/s41467-024-49739-3","volume":"15","author":"C Kagiou","year":"2024","unstructured":"Kagiou, C. et al. Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation. Nat. Commun. 15, 5409 (2024).","journal-title":"Nat. Commun."},{"key":"64669_CR40","doi-asserted-by":"publisher","first-page":"10358","DOI":"10.1021\/jacs.9b13391","volume":"142","author":"K McAulay","year":"2020","unstructured":"McAulay, K. et al. Alkynyl benzoxazines and dihydroquinazolines as cysteine targeting covalent warheads and their application in identification of selective irreversible kinase inhibitors. J. Am. Chem. Soc. 142, 10358\u201310372 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"64669_CR41","doi-asserted-by":"publisher","first-page":"11788","DOI":"10.1021\/acs.jmedchem.2c00909","volume":"65","author":"E Karaj","year":"2022","unstructured":"Karaj, E. et al. Tunable cysteine-targeting electrophilic heteroaromatic warheads induce ferroptosis. J. Med. Chem. 65, 11788\u201311817 (2022).","journal-title":"J. Med. Chem."},{"key":"64669_CR42","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/s41589-024-01655-9","volume":"20","author":"AA Basu","year":"2024","unstructured":"Basu, A. A. et al. A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation. Nat. Chem. Biol. 20, 1608\u20131616 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"64669_CR43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41589-024-01821-z","volume":"21","author":"X Zhang","year":"2025","unstructured":"Zhang, X., Simon, G. M. & Cravatt, B. F. Implications of frequent hitter E3 ligases in targeted protein degradation screens. Nat. Chem. Biol. 21, 474\u2013481 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"64669_CR44","doi-asserted-by":"publisher","first-page":"e0297122","DOI":"10.1371\/journal.pone.0297122","volume":"19","author":"C Lu","year":"2024","unstructured":"Lu, C. et al. AviTrap: a novel solution to achieve complete biotinylation. PLOS ONE 19, e0297122 (2024).","journal-title":"PLOS ONE"},{"key":"64669_CR45","doi-asserted-by":"crossref","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906 (2007).","DOI":"10.1038\/nprot.2007.261"},{"key":"64669_CR46","doi-asserted-by":"crossref","unstructured":"Rose, C. M. et al. Highly Multiplexed quantitative mass spectrometry analysis of ubiquitylomes. Cell Syst. 3, 394\u2013403 (2016).","DOI":"10.1016\/j.cels.2016.08.009"},{"key":"64669_CR47","doi-asserted-by":"publisher","first-page":"100477","DOI":"10.1016\/j.mcpro.2022.100477","volume":"22","author":"D Kohler","year":"2023","unstructured":"Kohler, D. et al. MSstatsPTM: statistical relative quantification of posttranslational modifications in bottom-up mass spectrometry-based proteomics. Mol. Cell. Proteom. 22, 100477 (2023).","journal-title":"Mol. Cell. Proteom."},{"key":"64669_CR48","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1074\/mcp.RA120.002105","volume":"19","author":"T Huang","year":"2020","unstructured":"Huang, T. et al. MSstatsTMT: statistical detection of differentially abundant proteins in experiments with isobaric labeling and multiple mixtures. Mol. Cell. Proteom. 19, 1706\u20131723 (2020).","journal-title":"Mol. Cell. Proteom."},{"key":"64669_CR49","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1021\/acs.jproteome.2c00834","volume":"22","author":"D Kohler","year":"2023","unstructured":"Kohler, D. et al. MSstats Version 4.0: statistical analyses of quantitative mass spectrometry-based proteomic experiments with chromatography-based quantification at scale. J. Proteome Res. 22, 1466\u20131482 (2023).","journal-title":"J. Proteome Res."},{"key":"64669_CR50","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res"},{"key":"64669_CR51","doi-asserted-by":"publisher","first-page":"7474","DOI":"10.1021\/acs.analchem.9b01682","volume":"91","author":"Z Kan","year":"2019","unstructured":"Kan, Z., Ye, X., Skinner, J. J., Mayne, L. & Englander, S. W. ExMS2: an integrated solution for hydrogen\u2013deuterium exchange mass spectrometry data analysis. Anal. Chem. 91, 7474\u20137481 (2019).","journal-title":"Anal. Chem."},{"key":"64669_CR52","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1021\/acs.analchem.6b03908","volume":"89","author":"BT Walters","year":"2017","unstructured":"Walters, B. T. Empirical method to accurately determine peptide-averaged protection factors from hydrogen exchange MS data. Anal. Chem. 89, 1049\u20131053 (2017).","journal-title":"Anal. Chem."},{"key":"64669_CR53","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41592-019-0459-y","volume":"16","author":"GR Masson","year":"2019","unstructured":"Masson, G. R. et al. Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments. Nat. Methods 16, 595\u2013602 (2019).","journal-title":"Nat. Methods"},{"key":"64669_CR54","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1038\/s41467-020-20143-x","volume":"11","author":"HR Maun","year":"2020","unstructured":"Maun, H. R. et al. Bivalent antibody pliers inhibit \u03b2-tryptase by an allosteric mechanism dependent on the IgG hinge. Nat. Commun. 11, 6435 (2020).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64669-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:02:11Z","timestamp":1762221731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64669-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64669"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64669-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6033426\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors own shares of Roche stock. The following authors are employees of Genentech: E.V., T.J., M.Z., H.G.B., B.T.W., A.L., K.S.L., X.Y., C.L.G., N.F.E., P.L.H., T.K.C., M.R.C., N.I., B.B., J.L., J.R. and R.L.Y. The remaining authors declare no additional competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9679"}}